Sequences of neural activity arise in many brain areas, including cortex, hippocampus, and central pattern generator circuits that underlie rhythmic behaviors like locomotion. While network architectures supporting sequence generation vary considerably, a common feature is an abundance of inhibition. In this work, we focus on architectures that support sequential activity in recurrently connected networks with inhibitiondominated dynamics. Specifically, we study emergent sequences in a special family of threshold-linear networks, called combinatorial threshold-linear networks (CTLNs), whose connectivity matrices are defined from directed graphs. Such networks naturally give rise to an abundance of sequences whose dynamics are tightly connected to the underlying graph. We find that architectures based on generalizations of cycle graphs produce limit cycle attractors that can be activated to generate transient or persistent (repeating) sequences. Each architecture type gives rise to an infinite family of graphs that can be built from arbitrary component subgraphs. Moreover, we prove a number of graph rules for the corresponding CTLNs in each family. The graph rules allow us to strongly constrain, and in some cases fully determine, the fixed points of the network in terms of the fixed points of the component subnetworks. Finally, we apply these results to identify all graphs up to size n = 5 that are parameter-independent core motifs. Core motifs are special graphs with a single fixed point that are in some sense irreducible, and typically support a single attractor. Additionally, we show how the structure of certain architectures gives insight into the sequential dynamics of the corresponding attractor.
Conclusion 49
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.